101 related articles for article (PubMed ID: 3752945)
1. Recombinant human leukocyte interferon induces alterations in the antigen phenotype of human breast carcinoma cells.
Greiner JW
Anticancer Res; 1986; 6(4):653-8. PubMed ID: 3752945
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of recombinant human leukocyte interferons on cell surface antigen expression.
Greiner JW; Fisher PB; Pestka S; Schlom J
Cancer Res; 1986 Oct; 46(10):4984-90. PubMed ID: 2944575
[TBL] [Abstract][Full Text] [Related]
3. Enhanced expression of surface tumor-associated antigens on human breast and colon tumor cells after recombinant human leukocyte alpha-interferon treatment.
Greiner JW; Hand PH; Noguchi P; Fisher PB; Pestka S; Schlom J
Cancer Res; 1984 Aug; 44(8):3208-14. PubMed ID: 6744259
[TBL] [Abstract][Full Text] [Related]
4. Increased surface expression and shedding of tumor associated antigens by human breast carcinoma cells treated with recombinant human interferons or phorbol ester tumor promoters.
Leon JA; Mesa-Tejada R; Gutierrez MC; Estabrook A; Greiner JW; Schlom J; Fisher PB
Anticancer Res; 1989; 9(6):1639-47. PubMed ID: 2516715
[TBL] [Abstract][Full Text] [Related]
5. Modulation of human tumor antigen expression.
Greiner JW; Hand PH; Colcher D; Weeks M; Thor A; Noguchi P; Pestka S; Schlom J
J Lab Clin Med; 1987 Mar; 109(3):244-61. PubMed ID: 2434589
[TBL] [Abstract][Full Text] [Related]
6. Effects of human recombinant alpha 2 arg-interferon and gamma-interferon on human breast cancer cell lines: dissociation of antiproliferative activity and induction of HLA-DR antigen expression.
Gastl G; Marth C; Leiter E; Gattringer C; Mayer I; Daxenbichler G; Flener R; Huber C
Cancer Res; 1985 Jul; 45(7):2957-61. PubMed ID: 3924395
[TBL] [Abstract][Full Text] [Related]
7. Differential responsiveness of cloned mammary carcinoma cell populations to the human recombinant leukocyte interferon enhancement of tumor antigen expression.
Greiner JW; Tobi M; Fisher PB; Langer JA; Pestka S
Int J Cancer; 1985 Aug; 36(2):159-66. PubMed ID: 3160671
[TBL] [Abstract][Full Text] [Related]
8. Expression and alterations of CD66 antigen by interferon-gamma in human breast carcinoma cell lines.
Sedlak J; Duraj J; Hunakova L; Chorvath B
Anticancer Res; 1994; 14(6B):2473-6. PubMed ID: 7872669
[TBL] [Abstract][Full Text] [Related]
9. Isolation and characterization of a human monoclonal antibody which reacts with breast and colorectal carcinoma.
Goldstein NI; Nagle R; Villar H; Hersh E; Fisher PB
Anticancer Res; 1990; 10(6):1491-500. PubMed ID: 1704693
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of surface antigen expression on human breast carcinoma cells by recombinant human interferons.
Tran R; Hand PH; Greiner JW; Pestka S; Schlom J
J Interferon Res; 1988 Feb; 8(1):75-88. PubMed ID: 3130426
[TBL] [Abstract][Full Text] [Related]
11. Improved radioimmunotherapeutic efficacy of an anticarcinoma monoclonal antibody (131I-CC49) when given in combination with gamma-interferon.
Greiner JW; Ullmann CD; Nieroda C; Qi CF; Eggensperger D; Shimada S; Steinberg SM; Schlom J
Cancer Res; 1993 Feb; 53(3):600-8. PubMed ID: 8425194
[TBL] [Abstract][Full Text] [Related]
12. Comparison of rates of phenotypic variability in surface antigen expression in normal and cancerous human breast epithelial cells.
Peterson JA; Ceriani RL; Blank EW; Osvaldo L
Cancer Res; 1983 Sep; 43(9):4291-6. PubMed ID: 6347369
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the interferon-gamma-mediated regulation of tumor-associated antigens expressed by human gastric carcinoma cells.
Shimada S; Ogawa M; Schlom J; Greiner JW
In Vivo; 1993; 7(1):1-8. PubMed ID: 8504201
[TBL] [Abstract][Full Text] [Related]
14. Modulation by recombinant DNA leukocyte (alpha) and fibroblast (beta) interferons of the expression and shedding of HLA- and tumor-associated antigens by human melanoma cells.
Giacomini P; Aguzzi A; Pestka S; Fisher PB; Ferrone S
J Immunol; 1984 Sep; 133(3):1649-55. PubMed ID: 6747299
[TBL] [Abstract][Full Text] [Related]
15. HLA-DR synthesis induction and expression in HLA-DR-negative carcinoma cell lines of diverse origins by interferon-gamma but not by interferon-beta.
Shaw AR; Chan JK; Reid S; Seehafer J
J Natl Cancer Inst; 1985 Jun; 74(6):1261-8. PubMed ID: 3923246
[TBL] [Abstract][Full Text] [Related]
16. Synergistic effects of IL-6 and IFN-gamma on carcinoembryonic antigen (CEA) and HLA expression by human colorectal carcinoma cells: role for endogenous IFN-beta.
Dansky-Ullmann C; Salgaller M; Adams S; Schlom J; Greiner JW
Cytokine; 1995 Feb; 7(2):118-29. PubMed ID: 7780031
[TBL] [Abstract][Full Text] [Related]
17. Definition of antigenic heterogeneity and modulation among human mammary carcinoma cell populations using monoclonal antibodies to tumor-associated antigens.
Hand PH; Nuti M; Colcher D; Schlom J
Cancer Res; 1983 Feb; 43(2):728-35. PubMed ID: 6848188
[TBL] [Abstract][Full Text] [Related]
18. Differential modulation by recombinant immune interferon of the expression and shedding of HLA antigens and melanoma associated antigens by a melanoma cell line resistant to the antiproliferative activity of immune interferon.
Ziai MR; Imberti L; Tongson A; Ferrone S
Cancer Res; 1985 Nov; 45(11 Pt 2):5877-82. PubMed ID: 3931909
[TBL] [Abstract][Full Text] [Related]
19. Major histocompatibility complex class II antigen and costimulatory molecule expression on the surface of breast cancer cells.
Fan P; Wang S; Liu X; Zhen L; Wu Z
Zhonghua Zhong Liu Za Zhi; 2002 Jul; 24(4):327-30. PubMed ID: 12408756
[TBL] [Abstract][Full Text] [Related]
20. Selective interferon-induced enhancement of tumor-associated antigens on a spectrum of freshly isolated human adenocarcinoma cells.
Guadagni F; Schlom J; Johnston WW; Szpak CA; Goldstein D; Smalley R; Simpson JF; Borden EC; Pestka S; Greiner JW
J Natl Cancer Inst; 1989 Apr; 81(7):502-12. PubMed ID: 2466127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
